Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382 · see citing works

AMPK: guardian of metabolism and mitochondrial homeostasis

Herzig, S., & Shaw, R. J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,094 · see citing works

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689 · see citing works

The mechanisms of action of metformin

Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287 · see citing works

Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease

Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · see citing works

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597 · see citing works

Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration

Deczkowska, A., Keren-Shaul, H., Weiner, A., Colonna, M., Schwartz, M., & Amit, I. (2018) · Cell · doi:10.1016/j.cell.2018.05.003 · Cited by 1,474 · see citing works

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., Iannaccone, S. T., Kirschner, J., Kuntz, N. L., Saito, K., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710504 · Cited by 1,433 · see citing works

Lactate in the brain: from metabolic end-product to signalling molecule

Magistretti, P. J., & Allaman, I. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.19 · Cited by 1,298 · see citing works

Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease

Kivipelto, M., Mangialasche, F., & Ngandu, T. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0070-3 · Cited by 1,173 · see citing works

The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet

Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.04.027 · Cited by 1,057 · see citing works

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001 · see citing works

Myelination of the Nervous System: Mechanisms and Functions

Nave, K., & Werner, H. B. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013101 · Cited by 1,000 · see citing works

The Biology of Huntingtin

Saudou, F., & Humbert, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.003 · Cited by 945 · see citing works

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models

Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Gonçalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0275-4 · Cited by 935 · see citing works

Brain Glucose Metabolism: Integration of Energetics with Function

Dienel, G. A. (2018) · Physiological Reviews · doi:10.1152/physrev.00062.2017 · Cited by 877 · see citing works

Mitochondria as a therapeutic target for common pathologies

Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 832 · see citing works

Multi-sensory Gamma Stimulation Ameliorates Alzheimer’s-Associated Pathology and Improves Cognition

Martorell, A. J., Paulson, A. L., Suk, H.-J., Abdurrob, F., Drummond, G. T., Guan, W., Young, J. Z., Kim, D. N.-W., Kritskiy, O., Barker, S. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.014 · Cited by 798 · see citing works

Physical activity and muscle-brain crosstalk

Pedersen, B. K. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0174-x · Cited by 772 · see citing works

Brain metabolism in health, aging, and neurodegeneration

Camandola, S., & Mattson, M. P. (2017) · The EMBO Journal · doi:10.15252/embj.201695810 · Cited by 752 · see citing works

Metabolic Regulation of Gene Expression by Histone Lysine β-Hydroxybutyrylation

Xie, Z., Zhang, D., Chung, D., Tang, Z., Huang, H., Dai, L., Qi, S., Li, J., Colak, G., Chen, Y., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.036 · Cited by 744 · see citing works

Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes

Ferrannini, E., Baldi, S., Frascerra, S., Astiarraga, B., Heise, T., Bizzotto, R., Mari, A., Pieber, T. R., & Muscelli, E. (2016) · Diabetes · doi:10.2337/db15-1356 · Cited by 713 · see citing works

Vascular dysfunction—The disregarded partner of Alzheimer's disease

Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711 · see citing works

AUTACs: Cargo-Specific Degraders Using Selective Autophagy

Takahashi, D., Moriyama, J., Nakamura, T., Miki, E., Takahashi, E., Sato, A., Akaike, T., Itto-Nakama, K., & Arimoto, H. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.009 · Cited by 675 · see citing works

Disturbed mitochondrial dynamics and neurodegenerative disorders

Burté, F., Carelli, V., Chinnery, P. F., & Yu‐Wai‐Man, P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.228 · Cited by 659 · see citing works

Shining light on the head: Photobiomodulation for brain disorders

Hamblin, M. R. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.09.002 · Cited by 630 · see citing works

Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity

Sorrentino, V., Romani, M., Mouchiroud, L., Beck, J. S., Zhang, H., D’Amico, D., Moullan, N., Potenza, F., Schmid, A. W., Rietsch, S., et al. (2017) · Nature · doi:10.1038/nature25143 · Cited by 630 · see citing works

Intermittent metabolic switching, neuroplasticity and brain health

Mattson, M. P., Moehl, K., Ghena, N., Schmaedick, M., & Cheng, A. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.156 · Cited by 624 · see citing works

Perimenopause as a neurological transition state

Brinton, R. D., Yao, J., Yin, F., Mack, W. J., & Cadenas, E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.82 · Cited by 612 · see citing works

Distinct Profiles of Myelin Distribution Along Single Axons of Pyramidal Neurons in the Neocortex

Tomassy, G. S., Berger, D. R., Chen, H.-H., Kasthuri, N., Hayworth, K. J., Vercelli, A., Seung, H. S., Lichtman, J. W., & Arlotta, P. (2014) · Science · doi:10.1126/science.1249766 · Cited by 600 · see citing works

Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism

Saab, A. S., Tzvetavona, I. D., Trevisiol, A., Baltan, S., Dibaj, P., Kusch, K., Möbius, W., Goetze, B., Jahn, H. M., Huang, W., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.016 · Cited by 590 · see citing works

GDF15 mediates the effects of metformin on body weight and energy balance

Coll, A. P., Chen, M., Taskar, P., Rimmington, D., Patel, S., Tadross, J. A., Cimino, I., Yang, M., Welsh, P., Virtue, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1911-y · Cited by 584 · see citing works

Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications

Penninx, B. W. J. H., & Lange, S. M. M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/bpenninx · Cited by 566 · see citing works

Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1

Morland, C., Andersson, K. A., Haugen, Ø. P., Hadzic, A., Kleppa, L., Gille, A., Rinholm, J. E., Palibrk, V., Diget, E. H., Kennedy, L. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15557 · Cited by 559 · see citing works

Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing

Boland, B., Yu, W. H., Corti, O., Mollereau, B., Henriques, A., Bézard, E., Pastores, G., Rubinsztein, D. C., Nixon, R. A., Duchen, M. R., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.109 · Cited by 552 · see citing works

Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements

Mookerjee, S. A., Gerencser, A. A., Nicholls, D. G., & Brand, M. D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.774471 · Cited by 550 · see citing works

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548 · see citing works

Alzheimer's disease as homeostatic responses to age-related myelin breakdown

Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546 · see citing works

Lactate mediates the effects of exercise on learning and memory through SIRT1-dependent activation of hippocampal brain-derived neurotrophic factor (BDNF)

El Hayek, L., Khalifeh, M., Zibara, V., Abi Assaad, R., Emmanuel, N., Karnib, N., El-Ghandour, R., Nasrallah, P., Bilen, M., Ibrahim, P., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1661-18.2019 · Cited by 539 · see citing works

Effects of β-hydroxybutyrate on cognition in memory-impaired adults

Reger, M. A., Henderson, S. T., Hale, C. M., Cholerton, B., Baker, L. D., Watson, G. S., Hyde, K., Chapman, D., & Craft, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00087-3 · Cited by 510 · see citing works

D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318797 · Cited by 497 · see citing works

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00108 · Cited by 480 · see citing works

NAD ⁺ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency

Hou, Y., Lautrup, S., Cordonnier, S., Wang, Y., Croteau, D. L., Zavala, E., Zhang, Y., Moritoh, K., O’Connell, J. F., Baptiste, B. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718819115 · Cited by 472 · see citing works

Evidence for brain glucose dysregulation in Alzheimer’s disease

An, Y., Varma, V., Varma, S., Casanova, R., Dammer, E., Pletnikova, O., Chia, C. W., Egan, J. M., Ferrucci, L., Troncoso, J., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.011 · Cited by 454 · see citing works

ApoE4: an emerging therapeutic target for Alzheimer’s disease

Safieh, M., Korczyn, A. D., & Michaelson, D. M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1299-4 · Cited by 449 · see citing works

The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease

McManus, M. J., Murphy, M. P., & Franklin, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0552-11.2011 · Cited by 432 · see citing works

Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans

Stekovic, S., Hofer, S. J., Tripolt, N., Aon, M. A., Royer, P., Pein, L., Stadler, J. T., Pendl, T., Prietl, B., Url, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.016 · Cited by 412 · see citing works

Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin

Moore, E. M., Mander, A. G., Ames, D. J., Kotowicz, M. A., Carne, R. P., Brodaty, H., Woodward, M., Boundy, K. L., Ellis, K. A., Bush, A. I., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0229 · Cited by 405 · see citing works

An evolutionary perspective on immunometabolism

Wang, A., Luan, H. H., & Medzhitov, R. M. (2019) · Science · doi:10.1126/science.aar3932 · Cited by 394 · see citing works

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383 · see citing works

Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice

Ou, Z., Kong, X., Sun, X., He, X., Zhang, L., Gong, Z., Huang, J., Xu, B., Long, D., Li, J., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.12.009 · Cited by 370 · see citing works

Dietary ketosis enhances memory in mild cognitive impairment

Krikorian, R., Shidler, M. D., Dangelo, K. N., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.006 · Cited by 365 · see citing works

A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease

Kashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363 · see citing works

Effects of the Insulin Sensitizer Metformin in Alzheimer Disease

Koenig, A. M., Mechanic-Hamilton, D. J., Xie, S. X., Combs, M., Cappola, A. R., Xie, L., Detre, J. A., Wolk, D. A., & Arnold, S. E. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000202 · Cited by 352 · see citing works

Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models

Gong, B., Pan, Y., Vempati, P., Zhao, W., Knable, L., Ho, L., Wang, J., Sastre, M., Ono, K., Sauve, A. A., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.005 · Cited by 345 · see citing works

The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson's disease

Schöndorf, D. C., Ivanyuk, D., Baden, P., Sanchez-Martinez, A., De Cicco, S., Yu, C., Giunta, I., Schwarz, L. K., Di Napoli, G., Panagiotakopoulou, V., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.009 · Cited by 337 · see citing works

Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial

Craft, S., Claxton, A., Baker, L. D., Hanson, A. J., Cholerton, B., Trittschuh, E. H., Dahl, D., Caulder, E., Neth, B., Montine, T. J., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161256 · Cited by 335 · see citing works

GLUT4 Mobilization Supports Energetic Demands of Active Synapses

Ashrafi, G., Wu, Z., Farrell, R. J., & Ryan, T. A. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.020 · Cited by 328 · see citing works

Loss of Brain Aerobic Glycolysis in Normal Human Aging

Goyal, M. S., Vlassenko, A. G., Blazey, T. M., Su, Y., Couture, L. E., Durbin, T. J., Bateman, R. J., Benzinger, T. L.-S., Morris, J. C., & Raichle, M. E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.010 · Cited by 318 · see citing works

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Baglioni, P. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1902837 · Cited by 316 · see citing works

The Therapeutic Potential of Metformin in Neurodegenerative Diseases

Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 310 · see citing works

Gene therapy for neurological disorders: progress and prospects

Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.110 · Cited by 306 · see citing works

Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice

Ma, D., Wang, A. C., Parikh, I. J., Green, S. J., Hoffman, J. D., Chlipala, G. E., Murphy, M. P., Sokola, B. S., Bauer, B., Hartz, A. M. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25190-5 · Cited by 300 · see citing works

The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease

Forny‐Germano, L., Felice, F. G. D., & Vieira, M. N. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01027 · Cited by 298 · see citing works

Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial

Phillips, M. C. L., Murtagh, D. K. J., Gilbertson, L. J., Asztely, F. J. S., & Lynch, C. D. P. (2018) · Movement Disorders · doi:10.1002/mds.27390 · Cited by 292 · see citing works

Metformin Use Associated With Reduced Risk of Dementia in Patients With Diabetes: A Systematic Review and Meta-Analysis

Campbell, J. M., Stephenson, M. D., de Courten, B., Chapman, I., Bellman, S. M., & Aromataris, E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180263 · Cited by 292 · see citing works

Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes

Zhao, N., Liu, C.-C., Van Ingelgom, A. J., Martens, Y. A., Linares, C., Knight, J. A., Painter, M. M., Sullivan, P. M., & Bu, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.003 · Cited by 289 · see citing works

Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases

Cai, R., Zhang, Y., Simmering, J. E., Schultz, J. L., Li, Y., Fernandez-Carasa, I., Consiglio, A., Raya, A., Polgreen, P. M., Narayanan, N. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129987 · Cited by 286 · see citing works

Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial

Luchsinger, J. A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., & Bagiella, E. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150493 · Cited by 285 · see citing works

Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance

Bakker, A., Albert, M., Krauss, G. L., Speck, C. L., & Gallagher, M. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.02.009 · Cited by 284 · see citing works

The role of type 2 diabetes in neurodegeneration

Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 276 · see citing works

Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease

Ota, M., Matsuo, J., Ishida, I., Takano, H., Yokoi, Y., Hori, H., Yoshida, S., Ashida, K., Nakamura, K., Takahashi, T., et al. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.10.048 · Cited by 276 · see citing works

Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease

Taylor, M., Sullivan, D. K., Mahnken, J. D., Burns, J. M., & Swerdlow, R. H. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.11.002 · Cited by 273 · see citing works

Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms

Fu, S., Wang, J., Xue, W.-J., Liu, H., Liu, B.-R., Zeng, Y., Li, S., Huang, B., Lv, Q.-K., Wang, W., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0230-3 · Cited by 269 · see citing works

The interneuron energy hypothesis: Implications for brain disease

Kann, O. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.005 · Cited by 266 · see citing works

Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases

Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266 · see citing works

The metabolic face of migraine — from pathophysiology to treatment

Gross, E. C., Martinez, M. L., Fischer, D., Sándor, P. S., & Schoenen, J. E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0255-4 · Cited by 263 · see citing works

Energy metabolism in ALS: an underappreciated opportunity?

Vandoorne, T., Bock, K. D., & Bosch, L. V. D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1835-x · Cited by 260 · see citing works

Inhibition of Drp1 ameliorates synaptic depression, Aβ deposition, and cognitive impairment in an Alzheimer’s disease model

Baek, S. H., Park, S. J., Jeong, J. I., Kim, S. H., Han, J., Kyung, J. W., Baik, S.-H., Choi, Y., Choi, B. Y., Park, J. S., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2385-16.2017 · Cited by 258 · see citing works

A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment, and early Alzheimer’s disease

Croteau, E., Castellano, C. A., Fortier, M., Bocti, C., Fulop, T., Paquet, N., & Cunnane, S. C. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.07.004 · Cited by 258 · see citing works

Energy Inhibition Elevates β-Secretase Levels and Activity and Is Potentially Amyloidogenic in APP Transgenic Mice: Possible Early Events in Alzheimer's Disease Pathogenesis

Velliquette, R. A., O'Connor, T., & Vassar, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2350-05.2005 · Cited by 254 · see citing works

Retinal metabolism: A comparative look at energetics in the retina

Country, M. W. (2017) · Brain Research · doi:10.1016/j.brainres.2017.07.025 · Cited by 254 · see citing works

Erratum: Gene therapy for neurological disorders: progress and prospects

Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.158 · Cited by 248 · see citing works

O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond

Yuzwa, S. A., & Vocadlo, D. J. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00038b · Cited by 247 · see citing works

Targeting pericytes for therapeutic approaches to neurological disorders

Cheng, J., Korte, N., Nortley, R., Sethi, H., Tang, Y., & Attwell, D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1893-0 · Cited by 245 · see citing works

α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson’s disease

Levine, P. M., Galesic, A., Balana, A. T., Mahul‐Mellier, A., Navarro, M. X., Leon, C. A. D., Lashuel, H. A., & Pratt, M. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808845116 · Cited by 240 · see citing works

Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study

Mosconi, L., Rahman, A., Diaz, I., Wu, X. L., Scheyer, O., Hristov, H., Vallabhajosula, S., Isaacson, R., de Leon, M. J., & Brinton, R. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207885 · Cited by 239 · see citing works

Subjective memory complaints, education, and risk of Alzheimer's disease

van Oijen, M., de Jong, F. J., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.01.011 · Cited by 238 · see citing works

Non‐signalling energy use in the brain

Engl, E., & Attwell, D. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.282517 · Cited by 230 · see citing works

Alzheimer’s Disease: From Firing Instability to Homeostasis Network Collapse

Frère, S. G. A., & Slutsky, I. (2018) · Neuron · doi:10.1016/j.neuron.2017.11.028 · Cited by 230 · see citing works

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia

Yang, L., Wang, H., Liu, L., & Xie, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00073 · Cited by 228 · see citing works

Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer’s Disease

Cunnane, S. C., Courchesne‐Loyer, A., Vandenberghe, C., St‐Pierre, V., Fortier, M., Hennebelle, M., Croteau, É., Bocti, C., Fülöp, T., & Castellano, C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00053 · Cited by 224 · see citing works

The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet

Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.06.051 · Cited by 224 · see citing works

Human Inflammaging

Fülöp, T., Larbi, A., & Witkowski, J. M. (2019) · Gerontology · doi:10.1159/000497375 · Cited by 221 · see citing works

A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment

Fortier, M., Castellano, C., Croteau, É., Langlois, F., Bocti, C., St‐Pierre, V., Vandenberghe, C., Bernier, M., Roy, M., Descoteaux, M., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.12.017 · Cited by 220 · see citing works

What Happens with the Circuit in Alzheimer's Disease in Mice and Humans?

Zott, B., Busche, M. A., Sperling, R. A., & Konnerth, A. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061725 · Cited by 215 · see citing works

Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease

Zeitler, B., Froelich, S., Marlen, K., Shivak, D. A., Yu, Q., Li, D., Pearl, J. R., Miller, J. C., Zhang, L., Paschon, D. E., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0478-3 · Cited by 215 · see citing works

APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis

Uddin, M. S., Kabir, M. T., Al Mamun, A., Abdel-Daim, M. M., Barreto, G. E., & Ashraf, G. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1237-z · Cited by 212 · see citing works

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age

Wingo, A. P., Dammer, E. B., Breen, M. S., Logsdon, B. A., Duong, D. M., Troncosco, J. C., Thambisetty, M., Beach, T. G., Serrano, G. E., Reiman, E. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09613-z · Cited by 211 · see citing works

The energetic brain—A review from students to students

Bordone, M. P., Salman, M. M., Titus, H. E., Amini, E., Andersen, J. V., Chakraborti, B., Diuba, A. V., Dubouskaya, T. G., Ehrke, E., Espindola de Freitas, A., et al. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14829 · Cited by 205 · see citing works

Glia-neuron energy metabolism in health and diseases: New insights into the role of nervous system metabolic transporters

Jha, M. K., & Morrison, B. M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.07.009 · Cited by 203 · see citing works

Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models

Hölscher, C. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.040 · Cited by 201 · see citing works

The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction

Zilberter, Y., & Zilberter, M. Y. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24064 · Cited by 199 · see citing works

Mitochondrial dynamics and transport in Alzheimer's disease

Flannery, P. J., & Trushina, E. V. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.06.009 · Cited by 198 · see citing works

Intermediates of Metabolism: From Bystanders to Signalling Molecules

Haas, R., Cucchi, D., Smith, J., Pucino, V., Macdougall, C. E., & Mauro, C. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.02.003 · Cited by 193 · see citing works

Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study

Neth, B., Mintz, A., Whitlow, C. T., Jung, Y., Sai, K., Register, T., Kellar, D., Lockhart, S., Hoscheidt, S., Maldjian, J., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.015 · Cited by 191 · see citing works

Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention

Wu, L., Zhang, X., & Zhao, L. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2262-17.2018 · Cited by 185 · see citing works

AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort

Al-Zaidy, S. A., Kolb, S. J., Lowes, L., Alfano, L. N., Shell, R., Church, K. R., Nagendran, S., Sproule, D. M., Feltner, D. E., Wells, C., et al. (2019) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-190403 · Cited by 185 · see citing works

A Ketogenic Diet Improves Mitochondrial Biogenesis and Bioenergetics via the PGC1α-SIRT3-UCP2 Axis

Hasan‐Olive, M. M., Lauritzen, K. H., Ali, M., Rasmussen, L. J., Storm‐Mathisen, J., & Bergersen, L. H. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2588-6 · Cited by 182 · see citing works

Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology

Nuriel, T., Angulo, S. L., Khan, U., Ashok, A., Chen, Q., Figueroa, H. Y., Emrani, S., Liu, L., Herman, M., Barrett, G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01444-0 · Cited by 181 · see citing works

Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study

Dellinger, R. W., Santos, S. R., Morris, M., Evans, M., Alminana, D., Guarente, L., & Marcotulli, E. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0016-9 · Cited by 181 · see citing works

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Larsen, S. B., Hanss, Z., & Krüger, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2768-8 · Cited by 181 · see citing works

Influence of young adult cognitive ability and additional education on later-life cognition

Kremen, W. S., Beck, A., Elman, J. A., Gustavson, D. E., Reynolds, C. A., Tu, X. M., Sanderson-Cimino, M. E., Panizzon, M. S., Vuoksimaa, E., Toomey, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811537116 · Cited by 180 · see citing works

Neuroglial Transmission

Gundersen, V., Storm‐Mathisen, J., & Bergersen, L. H. (2015) · Physiological Reviews · doi:10.1152/physrev.00024.2014 · Cited by 172 · see citing works

Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity

Mańczak, M., Kandimalla, R. J. L., Yin, X., & Reddy, P. H. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy335 · Cited by 170 · see citing works

Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study

Courchesne-Loyer, A., Croteau, E., Castellano, C.-A., St-Pierre, V., Hennebelle, M., & Cunnane, S. C. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16669366 · Cited by 169 · see citing works

Photobiomodulation with Near Infrared Light Helmet in a Pilot, Placebo Controlled Clinical Trial in Dementia Patients Testing Memory and Cognition

Berman, M. H., Halper, J. P., Nichols, T. W., Jarrett, H., Lundy, A., & Huang, J. H. (2017) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000176 · Cited by 168 · see citing works

The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer’s disease

Işık, A. T., Soysal, P., Yay, A., & Usarel, C. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.12.010 · Cited by 166 · see citing works

White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease

Klosinski, L. P., Yao, J., Yin, F., Fonteh, A. N., Harrington, M. G., Christensen, T. A., Trushina, E. V., & Brinton, R. D. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.002 · Cited by 164 · see citing works

Gut-Brain Glucose Signaling in Energy Homeostasis

Soty, M., Gautier‐Stein, A., Rajas, F., & Mithieux, G. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.032 · Cited by 163 · see citing works

Astrocytic glycogen metabolism in the healthy and diseased brain

Bak, L. K., Walls, A. B., Schousboe, A., & Waagepetersen, H. S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.803239 · Cited by 163 · see citing works

Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease

Bayliss, J. A., Lemus, M. B., Stark, R., dos Santos, V. V., Thompson, A., Rees, D. J., Galić, S., Elsworth, J. D., Kemp, B. E., Davies, J. S., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4373-15.2016 · Cited by 161 · see citing works

Medium-Chain Fatty Acids Improve Cognitive Function in Intensively Treated Type 1 Diabetic Patients and Support In Vitro Synaptic Transmission During Acute Hypoglycemia

Page, K. A., Williamson, A., Yu, N., McNay, E. C., Dzuira, J. D., McCrimmon, R. J., & Sherwin, R. S. (2009) · Diabetes · doi:10.2337/db08-1557 · Cited by 159 · see citing works

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons

Zambon, F., Cherubini, M., Fernandes, H. J. R., Lang, C., Ryan, B. J., Volpato, V., Bengoa‐Vergniory, N., Vingill, S., Attar, M., Booth, H., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz038 · Cited by 156 · see citing works

Metformin selectively targets redox control of complex I energy transduction

Cameron, A., Logie, L., Patel, K. A., Erhardt, S., Bacon, S., Middleton, P. K., Harthill, J. E., Forteath, C., Coats, J. T., Kerr, C., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.018 · Cited by 153 · see citing works

Microglia-Specific Metabolic Changes in Neurodegeneration

Aldana, B. I. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.03.006 · Cited by 153 · see citing works

Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice

Polyzos, A. A., Lee, D. Y., Datta, R., Hauser, M., Budworth, H., Holt, A., Mihalik, S. J., Goldschmidt, P., Frankel, K. A., Trego, K. S., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.004 · Cited by 152 · see citing works

Monitoring ATP dynamics in electrically active white matter tracts

Trevisiol, A., Saab, A. S., Winkler, U., Marx, G., Imamura, H., Möbius, W., Kusch, K., Nave, K.-A., & Hirrlinger, J. (2017) · eLife · doi:10.7554/elife.24241 · Cited by 151 · see citing works

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease

Bido, S., Soria, F. N., Fan, R. Z., Bézard, E., & Tieu, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-07181-0 · Cited by 151 · see citing works

Priming of microglia with IFN-γ slows neuronal gamma oscillations in situ

Ta, T., Dikmen, H. O., Schilling, S., Chausse, B., Lewen, A., Hollnagel, J., & Kann, O. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813562116 · Cited by 151 · see citing works

Longitudinal RNA-Seq Analysis of Vertebrate Aging Identifies Mitochondrial Complex I as a Small-Molecule-Sensitive Modifier of Lifespan

Baumgart, M., Priebe, S., Groth, M., Hartmann, N., Menzel, U., Pandolfini, L., Koch, P., Felder, M., Ristow, M., Englert, C., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.01.014 · Cited by 147 · see citing works

Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: An integrative review

Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 146 · see citing works

The glucose transporter type 1 (Glut1) syndromes

Koch, H., & Weber, Y. G. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.06.010 · Cited by 144 · see citing works

Lactate is an antidepressant that mediates resilience to stress by modulating the hippocampal levels and activity of histone deacetylases

Karnib, N., El-Ghandour, R., Hayek, L. E., Nasrallah, P., Khalifeh, M., Barmo, N., Jabre, V., Ibrahim, P., Bilen, M., Stephan, J. S., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0313-z · Cited by 144 · see citing works

Transcranial low-level laser therapy improves brain mitochondrial function and cognitive impairment in D-galactose–induced aging mice

Salehpour, F., Ahmadian, N., Rasta, S. H., Farhoudi, M., Karimi, P., & Sadigh‐Eteghad, S. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.025 · Cited by 141 · see citing works

Neuroketotherapeutics: A modern review of a century-old therapy

Koppel, S. J., & Swerdlow, R. H. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.019 · Cited by 140 · see citing works

Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis

Miquel, E., Cassina, A., Palma, L. M., Souza, J. M., Bolatto, C., Rodríguez-Bottero, S., Logan, A., Smith, R. A. J., Murphy, M. P., Barbeito, L., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.019 · Cited by 139 · see citing works

Cortical hypermetabolism in MCI subjects: a compensatory mechanism?

Ashraf, A., Fan, Z., Brooks, D. J., & Edison, P. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2919-z · Cited by 136 · see citing works

Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4−/−: A double-blind, randomized, placebo-controlled crossover trial

Xu, Q., Zhang, Y., Zhang, X., Liu, L., Zhou, B., Mo, R., Li, Y., Li, H., Li, F., Yang, T., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.10.017 · Cited by 136 · see citing works

Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease

Zhao, W., Varghese, M., Vempati, P., Dzhun, A., Cheng, A., Wang, J., Lange, D. J., Bilski, A. E., Faravelli, I., & Pasinetti, G. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049191 · Cited by 135 · see citing works

Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease

Croteau, E., Castellano, C.-A., Richard, M. A., Fortier, M., Nugent, S., Lepage, M., Duchesne, S., Whittingstall, K., Turcotte, É. E., Bocti, C., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180202 · Cited by 135 · see citing works

Energetic and nutritional constraints on infant brain development: Implications for brain expansion during human evolution

Cunnane, S. C., & Crawford, M. A. (2014) · Journal of Human Evolution · doi:10.1016/j.jhevol.2014.05.001 · Cited by 134 · see citing works

How to reprogram microglia toward beneficial functions

Fumagalli, M., Lombardi, M., Gressèns, P., & Verderio, C. (2018) · Glia · doi:10.1002/glia.23484 · Cited by 134 · see citing works

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model

Sayed, N. H., Fathy, N., Kortam, M. A., Rabie, M. A., Mohamed, A. F., & Kamel, A. S. E. D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00805-5 · Cited by 134 · see citing works

Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease

Tai, J., Liu, W., Li, Y., Li, L., & Hölscher, C. (2017) · Brain Research · doi:10.1016/j.brainres.2017.10.012 · Cited by 133 · see citing works

Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets

Vieira, M. N. N., Lima‐Filho, R. A. S., & Felice, F. G. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.014 · Cited by 131 · see citing works

Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism

Ahmed, R. M., Irish, M., Piguet, O., Halliday, G. M., Ittner, L. M., Farooqi, I. S., Hodges, J. R., & Kiernan, M. C. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00380-4 · Cited by 130 · see citing works

Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases

Clemmensen, C., Finan, B., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Hofmann, S. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0118-x · Cited by 129 · see citing works

Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention

Briston, T., & Hicks, A. R. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180025 · Cited by 129 · see citing works

Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells

Nakamura, T., Watanabe, A., Fujino, T., Hosono, T., & Michikawa, M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-35 · Cited by 124 · see citing works

Metformin reverses early cortical network dysfunction and behavior changes in Huntington’s disease

Arnoux, I., Willam, M., Griesche, N., Krummeich, J., Watari, H., Offermann, N., Weber, S. S., Dey, P. N., Chen, C., Monteiro, O., et al. (2018) · eLife · doi:10.7554/elife.38744 · Cited by 117 · see citing works

Insulin regulates POMC neuronal plasticity to control glucose metabolism

Dodd, G. T., Michael, N. J., Lee, R. S., Mangiafico, S. P., Pryor, J. T., Munder, A. C., Simonds, S. E., Brüning, J. C., Zhang, Z., Cowley, M. A., et al. (2018) · eLife · doi:10.7554/elife.38704 · Cited by 116 · see citing works

The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies

Arenaza‐Urquijo, E. M., Przybelski, S. A., Lesnick, T. G., Graff‐Radford, J., Machulda, M. M., Knopman, D. S., Schwarz, C. G., Lowe, V. J., Mielke, M. M., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz037 · Cited by 112 · see citing works

Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease

Zhang, L., Zhang, S., Maezawa, I., Trushin, S., Minhas, P. S., Pinto, M., Jin, L., Prasain, K., Nguyen, T. D. T., Yamazaki, Y., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.03.009 · Cited by 110 · see citing works

Lactate administration reproduces specific brain and liver exercise‐related changes

Lezi, E., Lu, J., Selfridge, J. E., Burns, J. M., & Swerdlow, R. H. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12394 · Cited by 110 · see citing works

ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects

Zhao, Y., Sun, X., Hu, D., Prosdocimo, D. A., Hoppel, C. L., Jain, M. K., Ramachandran, R., & Qi, X. (2019) · Nature Communications · doi:10.1038/s41467-019-09291-x · Cited by 109 · see citing works

Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTg<scp>AD</scp> mouse model of Alzheimer's disease

Pawlosky, R. J., Kemper, M. F., Kashiwaya, Y., King, M. T., Mattson, M. P., & Veech, R. L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13958 · Cited by 108 · see citing works

Ketogenic Diet Prevents Alterations in Brain Metabolism in Young but not Adult Rats after Traumatic Brain Injury

Deng‐Bryant, Y., Prins, M. L., Hovda, D. A., & Harris, N. G. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1822 · Cited by 104 · see citing works

Insulin modulates hippocampally-mediated spatial working memory via glucose transporter-4

Pearson-Leary, J., Jahagirdar, V., Sage, J., & McNay, E. C. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.09.033 · Cited by 104 · see citing works

Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport

Hinckelmann, M.-V., Virlogeux, A., Niehage, C., Poujol, C., Choquet, D., Hoflack, B., Zala, D., & Saudou, F. (2016) · Nature Communications · doi:10.1038/ncomms13233 · Cited by 103 · see citing works

Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta‐analysis

Cao, B., Rosenblat, J. D., Brietzke, E. M., Park, C., Lee, Y. L., Musial, N., Pan, Z., Mansur, R. B., & McIntyre, R. S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13373 · Cited by 103 · see citing works

Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis

Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103 · see citing works

Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function

Orr, A. L., Kim, C., Jimenez-Morales, D., Newton, B. W., Johnson, J. R., Krogan, N. J., Swaney, D. L., & Mahley, R. W. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181184 · Cited by 103 · see citing works

In Vivo Mitochondrial and Glycolytic Impairments in Patients with Alzheimer Disease

Terada, T., Obi, T., Bunai, T., Matsudaira, T., Yoshikawa, E., Ando, I., Futatsubashi, M., Tsukada, H., & Ouchi, Y. (2020) · Neurology · doi:10.1212/wnl.0000000000009249 · Cited by 103 · see citing works

Triheptanoin improves brain energy metabolism in patients with Huntington disease

Adanyeguh, I. M., Rinaldi, D., Henry, P., Caillet, S., Valabrègue, R., Dürr, A., & Mochel, F. (2015) · Neurology · doi:10.1212/wnl.0000000000001214 · Cited by 102 · see citing works

FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease

Matthews, D. C., Lerman, H., Lukic, A., Andrews, R. D., Mirelman, A., Wernick, M. N., Giladi, N., Strother, S. C., Evans, K. C., Cedarbaum, J. M., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.08.006 · Cited by 100 · see citing works

Plasma Ketone and Medium Chain Fatty Acid Response in Humans Consuming Different Medium Chain Triglycerides During a Metabolic Study Day

St‐Pierre, V., Vandenberghe, C., Lowry, C.-M., Fortier, M., Castellano, C., Wagner, J. R., & Cunnane, S. C. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00046 · Cited by 100 · see citing works

Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments

Tefera, T. W., & Borges, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00611 · Cited by 99 · see citing works

Heptanoate as a Neural Fuel: Energetic and Neurotransmitter Precursors in Normal and Glucose Transporter I-Deficient (G1D) Brain

Marin‐Valencia, I., Good, L. B., Ma, Q., Malloy, C. R., & Pascual, J. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.151 · Cited by 98 · see citing works

The Contribution of Ketone Bodies to Basal and Activity-Dependent Neuronal Oxidation in Vivo

Chowdhury, G. M. I., Jiang, L., Rothman, D. L., & Behar, K. L. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.77 · Cited by 97 · see citing works

The co‐occurrence of mt DNA mutations on different oxidative phosphorylation subunits, not detected by haplogroup analysis, affects human longevity and is population specific

Raule, N., Sevini, F., Li, S., Barbieri, A., Tallaro, F., Lomartire, L., Vianello, D., Montesanto, A., Moilanen, J. S., Bezrukov, V. V., et al. (2013) · Aging Cell · doi:10.1111/acel.12186 · Cited by 97 · see citing works

Uniform distributions of glucose oxidation and oxygen extraction in gray matter of normal human brain: No evidence of regional differences of aerobic glycolysis

Hyder, F., Hermán, P., Bailey, C. J., Møller, A., Globinsky, R., Fulbright, R. K., Rothman, D. L., & GJEDDE, A. H. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15625349 · Cited by 97 · see citing works

Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer’s Disease: An Update

Silva, M. D. F., Dias, K. S. T., Gontijo, V. S., Ortiz, C. J. C., & Viegas, C. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180111101843 · Cited by 96 · see citing works

Gene Therapy for ALS—A Perspective

Cappella, M., Ciotti, C., Cohen-Tannoudji, M., & Biferi, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184388 · Cited by 96 · see citing works

Nutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS

Xin, L., İpek, Ö., Beaumont, M., Shevlyakova, M., Christinat, N., Masoodi, M., Greenberg, N., Rolf Gruetter, A., & Cuenoud, B. M. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00062 · Cited by 93 · see citing works

Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease

Brandt, J., Buchholz, A. S., Henry-Barron, B. J., Vizthum, D., Avramopoulos, D., & Cervenka, M. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180995 · Cited by 93 · see citing works

Glucagon like peptide-1 (GLP-1) likes Alzheimer’s disease

Simsir, I. Y., Soyaltın, U. E., & Çetinkalp, Ş. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.002 · Cited by 92 · see citing works

Gut-brain signaling in energy homeostasis: the unexpected role of microbiota-derived succinate

Vadder, F. D., & Mithieux, G. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0542 · Cited by 92 · see citing works

Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease

Zilberter, M. Y., Ivanov, A., Ziyatdinova, S., Mukhtarov, M. R., Malkov, A., Alpár, A., Tortoriello, G., Botting, C. H., Fülöp, L., Osypov, A. A., et al. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12127 · Cited by 91 · see citing works

Semaglutide: review and place in therapy for adults with type 2 diabetes

Goldenberg, R. M., & Steen, O. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.05.008 · Cited by 91 · see citing works

SIRT3 Haploinsufficiency Aggravates Loss of GABAergic Interneurons and Neuronal Network Hyperexcitability in an Alzheimer's Disease Model

Cheng, A., Wang, J., Ghena, N., Zhao, Q., Perone, I., King, T. M., Veech, R. L., Gorospe, M., Wan, R., & Mattson, M. P. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1446-19.2019 · Cited by 91 · see citing works

Targeting α-Synuclein in Parkinson’s Disease: Progress Towards the Development of Disease-Modifying Therapeutics

Savitt, D., & Jankovic, J. J. (2019) · Drugs · doi:10.1007/s40265-019-01104-1 · Cited by 89 · see citing works

C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis

Allen, S. P., Hall, B., Woof, R., Francis, L. I., Gatto, N., Shaw, A. C., Myszczynska, M. A., Hemingway, J., Coldicott, I., Willcock, A., et al. (2019) · Brain · doi:10.1093/brain/awz302 · Cited by 89 · see citing works

G lia in brain energy metabolism: A perspective

Barros, L. F., Brown, A. M., & Swanson, R. A. (2018) · Glia · doi:10.1002/glia.23316 · Cited by 89 · see citing works

Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis

Ngo, S. T., Steyn, F. J., Huang, L., Mantovani, S., Pfluger, C. M., Woodruff, T. M., O’Sullivan, J. D., Henderson, R. D., & McCombe, P. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.06.053 · Cited by 88 · see citing works

AP39, a Mitochondria‐Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer’s Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons

Zhao, F., Fang, F., Qiao, P., Yan, N., Gao, D., & Yan, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8360738 · Cited by 88 · see citing works

Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks

Correia, S. C., Perry, G. L., & Moreira, P. I. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.010 · Cited by 88 · see citing works

Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15years Experience

Roe, C. R., & Brunengraber, H. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.10.005 · Cited by 87 · see citing works

Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism

Lin, Y., Wang, K., Ma, C., Wang, X., Gong, Z., Zhang, R., Zang, D., & Cheng, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00227 · Cited by 87 · see citing works

Upregulation of GPR109A in Parkinson’s Disease

Wakade, C. G., Chong, R. K. Y., Bradley, E., Thomas, B., & Morgan, J. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109818 · Cited by 86 · see citing works

Brain Regions Showing White Matter Loss in Huntington’s Disease Are Enriched for Synaptic and Metabolic Genes

McColgan, P., Gregory, S., Seunarine, K. K., Razi, A., Papoutsi, M., Johnson, E. B., Dürr, A., Roos, R. A. C., Leavitt, B. R., Holmans, P., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.019 · Cited by 86 · see citing works

Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer’s disease. A systematic review and meta-analysis of human studies

Avgerinos, K., Egan, J., Mattson, M., & Kapogiannis, D. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.101001 · Cited by 86 · see citing works

Consequences of Metabolic Disruption in Alzheimer's Disease Pathology

Ryu, J. C., Zimmer, E. R., Rosa‐Neto, P., & Yoon, S. O. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00755-y · Cited by 84 · see citing works

Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model

Ari, C., Poff, A. M., Held, H. E., Landon, C. S., Goldhagen, C. R., Mavromates, N., & D’Agostino, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103526 · Cited by 82 · see citing works

Enhancement of Astroglial Aerobic Glycolysis by Extracellular Lactate-Mediated Increase in cAMP

Vardjan, N., Chowdhury, H. H., Horvat, A., Velebit, J., Malnar, M., Muhič, M., Kreft, M., KRIVEC, S. G., Bobnar, S. T., Miš, K., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00148 · Cited by 81 · see citing works

A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease

Ruskin, D. N., Ross, J. L., Kawamura, M., Ruiz, T., Geiger, J. D., & Masino, S. A. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.001 · Cited by 78 · see citing works

Post hoc analysis of the Exenatide‐ PD trial—Factors that predict response

Athauda, D. S., Maclagan, K., Budnik, N., Zampedri, L., Hibbert, S., Avilés-Olmos, I., Chowdhury, K., Skene, S. S., Limousin, P. D., & Foltynie, T. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14096 · Cited by 77 · see citing works

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases

Batista, A. F., Bodart‐Santos, V., Felice, F. G. D., & Ferreira, S. T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0593-6 · Cited by 77 · see citing works

Impairments in oxidative glucose metabolism in epilepsy and metabolic treatments thereof

McDonald, T., Puchowicz, M., & Borges, K. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00274 · Cited by 77 · see citing works

Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH ‐ SY 5Y cells

Jalewa, J., Sharma, M. K., & Hölscher, C. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13736 · Cited by 75 · see citing works

Hallmarks of neurodegenerative diseases

Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789 · see citing works

Mitochondrial dysfunction: mechanisms and advances in therapy

Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,274 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease

Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654 · see citing works

Astrocyte-neuron metabolic cooperation shapes brain activity

Bonvento, G., & Bolaños, J. P. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.006 · Cited by 580 · see citing works

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases

Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 450 · see citing works

Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441 · see citing works

Biomarkers of aging

Bao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 389 · see citing works

Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration.

Andersen, J. V., Markussen, K., Jakobsen, E., Schousboe, A., Waagepetersen, H., Rosenberg, P., & Aldana, B. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108719 · Cited by 331 · see citing works

Association between age at diabetes onset and subsequent risk of dementia

Barbiellini Amidei, C., Fayosse, A., Dumurgier, J., Machado-Fragua, M. D., Tabak, A. G., van Sloten, T., Kivimäki, M., Dugravot, A., Sabia, S., & Singh-Manoux, A. (2021) · JAMA · doi:10.1001/jama.2021.4001 · Cited by 355 · see citing works

Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration

Mi, Y., Qi, G., Vitali, F., Shang, Y., Raikes, A. C., Wang, T., Jin, Y., Brinton, R. D., Gu, H., & Yin, F. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00756-4 · Cited by 343 · see citing works

Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes

Lee, J., & Kim, H.-J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.931536 · Cited by 310 · see citing works

Metabolic and Signaling Roles of Ketone Bodies in Health and Disease

Puchalska, P., & Crawford, P. A. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-111120-111518 · Cited by 290 · see citing works

Energy matters: presynaptic metabolism and the maintenance of synaptic transmission

Li, S., & Sheng, Z. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00535-8 · Cited by 273 · see citing works

Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration

Cheng, X., Huang, N., & Sheng, Z. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.015 · Cited by 253 · see citing works

Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle

Andersen, J. V., Schousboe, A., & Verkhratsky, A. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102331 · Cited by 259 · see citing works

Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress

Dewanjee, S., Chakraborty, P., Bhattacharya, H., Chacko, L., Singh, B., Chaudhary, A., Javvaji, K., Pradhan, S. R., Vallamkondu, J., Dey, A., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.032 · Cited by 235 · see citing works

Glucose metabolic crosstalk and regulation in brain function and diseases

Zhang, S., Lachance, B. B., Mattson, M. P., & Jia, X. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102089 · Cited by 205 · see citing works

A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6‐month RCT

Fortier, M., Castellano, C., St‐Pierre, V., Myette‐Côté, É., Langlois, F., Roy, M., Morin, M., Bocti, C., Fülöp, T., Godin, J., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12206 · Cited by 190 · see citing works

Mitochondrial Dysfunction in Alzheimers Disease: Opportunities forDrug Development

Bhatia, S., Rawal, R., Sharma, P., Singh, T., Singh, M., & Singh, V. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210517114016 · Cited by 196 · see citing works

GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease

Zheng, J., Xie, Y., Ren, L., Qi, L., Wu, L., Pan, X., Zhou, J., Zhou, C., & Liu, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101180 · Cited by 185 · see citing works

Oligodendrocytes enhance axonal energy metabolism by deacetylation of mitochondrial proteins through transcellular delivery of SIRT2

Chamberlain, K. A., Huang, N., Xie, Y., Licausi, F., Li, S., Li, Y., & Sheng, Z. (2021) · Neuron · doi:10.1016/j.neuron.2021.08.011 · Cited by 180 · see citing works

Intranasal Insulin for Alzheimer’s Disease

Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 182 · see citing works

Adenosine signalling to astrocytes coordinates brain metabolism and function

Theparambil, S. M., Kopach, O., Braga, A., Nizari, S., Hosford, P. S., Sági‐Kiss, V., Hadjihambi, A., Konstantinou, C., Esteras, N., del Arroyo, A. G., et al. (2024) · Nature · doi:10.1038/s41586-024-07611-w · Cited by 168 · see citing works

Microglia and lipids: how metabolism controls brain innate immunity

Chausse, B., Kakimoto, P. A., & Kann, O. (2021) · Seminars in Cell &amp; Developmental Biology · doi:10.1016/j.semcdb.2020.08.001 · Cited by 181 · see citing works

Promotion of astrocyte-neuron glutamate-glutamine shuttle by SCFA contributes to the alleviation of Alzheimer's disease

Sun, Y., Zhang, H., Zhang, X., Wang, W., Chen, Y., Cai, Z., Wang, Q., Wang, J., & Shi, Y. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102690 · Cited by 151 · see citing works

The role of mitophagy in the regulation of mitochondrial energetic status in neurons

Han, S., Zhang, M., Jeong, Y. Y., Margolis, D. J., & Cai, Q. (2021) · Autophagy · doi:10.1080/15548627.2021.1907167 · Cited by 151 · see citing works

Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission — The essential roles of astrocytes

Andersen, J. V., & Schousboe, A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15811 · Cited by 151 · see citing works

Synapses: The Brain’s Energy-Demanding Sites

Faria‐Pereira, A., & Morais, V. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073627 · Cited by 145 · see citing works

Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches

Ding, P.-F., Zhang, H., Wang, J., Gao, Y., Mao, J.-N., Hang, C., & Li, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1092431 · Cited by 139 · see citing works

Glia fuel neurons with locally synthesized ketone bodies to sustain memory under starvation

Silva, B., Mantha, O. L., Schor, J., Pascual, A., Plaçais, P.-Y., Pavlowsky, A., & Préat, T. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00528-6 · Cited by 138 · see citing works

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments

Rehman, M. U., Sehar, N., Dar, N. J., Khan, A., Arafah, A., Rashid, S., Rashid, S. M., & Ganaie, M. A. (2023) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104961 · Cited by 130 · see citing works

Oligodendroglial fatty acid metabolism as a central nervous system energy reserve

Asadollahi, E., Trevisiol, A., Saab, A. S., Looser, Z. J., Dibaj, P., Ebrahimi, R., Kusch, K., Ruhwedel, T., Möbius, W., Jahn, O., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01749-6 · Cited by 130 · see citing works

Mitochondrial complex I as a therapeutic target for Alzheimer's disease

Trushina, E. V., Trushin, S., & Hasan, M. F. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.003 · Cited by 130 · see citing works

Brain Metabolic Alterations in Alzheimer’s Disease

Ardanaz, C. G., Ramírez, M. J., & Solas, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073785 · Cited by 130 · see citing works

Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway

Wang, Z.-J., Li, X.-R., Chai, S.-F., Li, W.-R., Li, S., Hou, M., Li, J.-L., Ye, Y.-C., Cai, H.-Y., Hölscher, C., et al. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109716 · Cited by 125 · see citing works

ESPEN guideline on nutrition and hydration in dementia – Update 2024

Volkert, D., Beck, A. M., Irving, G. F., Frühwald, T., Hooper, L., Keller, H., Porter, J. A., Rothenberg, E. M., Suominen, M. H., Wirth, R., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.04.039 · Cited by 121 · see citing works

Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine

Duo, Y., Han, L., Yang, Y., Wang, Z., Wang, L., Chen, J., Xiang, Z., Yoon, J., Luo, G., & Tang, B. Z. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00244 · Cited by 119 · see citing works

Effects of dietary restriction on neuroinflammation in neurodegenerative diseases

Fontana, L., Ghezzi, L., Cross, A. H., & Piccio, L. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190086 · Cited by 116 · see citing works

Exercise improves cognitive dysfunction and neuroinflammation in mice through Histone H3 lactylation in microglia

Han, H., Zhao, Y., Du, J., Wang, S., Yang, X., Li, W., Song, J., Zhang, S., Zhang, Z., Tan, Y., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00390-4 · Cited by 116 · see citing works

Aging drives cerebrovascular network remodeling and functional changes in the mouse brain

Bennett, H. C., Zhang, Q., Wu, Y.-T., Manjila, S. B., Chon, U., Shin, D., Vanselow, D. J., Pi, H.-J., Drew, P. J., & Kim, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-50559-8 · Cited by 109 · see citing works

Intranasal insulin

Hallschmid, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12934 · Cited by 113 · see citing works

Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials

Cheng, G., Liu, Y., Ma, R., Cheng, G., Guan, Y., Chen, X., Wu, Z., & Chen, T. (2022) · Nano-Micro Letters · doi:10.1007/s40820-022-00847-z · Cited by 110 · see citing works

Sinisan alleviates depression-like behaviors by regulating mitochondrial function and synaptic plasticity in maternal separation rats

Deng, D., Cui, Y., Gan, S., Xie, Z., Cui, S., Cao, K., Wang, S., Shi, G., Yang, L., Bai, S., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154395 · Cited by 109 · see citing works

Lactate metabolism in neurodegenerative diseases

Yang, C., Pan, R., Guan, F., & Yuan, Z. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374142 · Cited by 109 · see citing works

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases

Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022) · Aging and Disease · doi:10.14336/ad.2021.1217 · Cited by 109 · see citing works

Microtubules and cardiovascular diseases: insights into pathology and therapeutic strategies

Wu, Q., Wang, Y., Liu, J., Guan, X., Chang, X., Liu, Z., & Liu, R. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106650 · Cited by 109 · see citing works

Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases

Jang, J., Kim, S. R., Lee, J. E., Lee, S.-Y., Son, H. J., Choe, W., Yoon, K., Kim, S. S., Yeo, E., & Kang, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010124 · Cited by 107 · see citing works

Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer’s disease pathologic process via GPR41 and GPR43

Wang, Z., Wang, C., Yuan, B., Liu, L., Zhang, H., Zhu, M., Chai, H., Peng, J., Huang, Y. H., Zhou, S., et al. (2025) · Microbiome · doi:10.1186/s40168-024-02001-w · Cited by 112 · see citing works

A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease

Al-Kuraishy, H. M., Al-Gareeb, A. I., Alsayegh, A. A., Hakami, Z. H., Khamjan, N. A., Saad, ‏. M., Batiha, G. E., & WAARD, M. M. D. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03817-4 · Cited by 106 · see citing works

Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer’s disease

Andersen, J. V., Skotte, N. H., Christensen, S. K., Polli, F. S., Shabani, M., Markussen, K. H., Haukedal, H., Westi, E. W., Diaz-delCastillo, M., Sun, R. C., et al. (2021) · Cell Death &amp; Disease · doi:10.1038/s41419-021-04237-y · Cited by 104 · see citing works

Health Benefits, Food Applications, and Sustainability of Microalgae-Derived N-3 PUFA

Liu, Y., Ren, X., Fan, C., Wu, W., Zhang, W., & Wang, Y. (2022) · Foods · doi:10.3390/foods11131883 · Cited by 109 · see citing works

Molecular Mechanisms for Ketone Body Metabolism, Signaling Functions, and Therapeutic Potential in Cancer

Hwang, C. Y., Choe, W., Yoon, K., Ha, J., Kim, S. S., Yeo, E., & Kang, I. (2022) · Nutrients · doi:10.3390/nu14224932 · Cited by 105 · see citing works

Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress

Rummel, N. G., & Butterfield, D. A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0177 · Cited by 105 · see citing works

Focusing on mitochondria in the brain: from biology to therapeutics

Song, N., Mei, S., Wang, X.-X., Hu, G., & Lu, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00409-w · Cited by 102 · see citing works

Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling

Jadiya, P., Garbincius, J. F., & Elrod, J. W. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01224-4 · Cited by 94 · see citing works

Axonal energy metabolism, and the effects in aging and neurodegenerative diseases

Yang, S., Park, J. H., & Lu, H.-C. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00634-3 · Cited by 94 · see citing works

Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease

Austad, S. N., Ballinger, S. W., Buford, T. W., Carter, C. S., Smith, D. L., Darley-Usmar, V. M., & Zhang, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.014 · Cited by 93 · see citing works

Glucose metabolism, neural cell senescence and Alzheimer's disease

Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084351 · Cited by 90 · see citing works

TLR2- and TLR3-activated microglia induce different levels of neuronal network dysfunction in a context-dependent manner

Schilling, S., Chausse, B., Dikmen, H. O., Almouhanna, F., Hollnagel, J., Lewen, A., & Kann, O. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.013 · Cited by 91 · see citing works

Astrocyte metabolism of the medium-chain fatty acids octanoic acid and decanoic acid promotes GABA synthesis in neurons via elevated glutamine supply

Andersen, J. V., Westi, E. W., Jakobsen, E., Urruticoechea, N., Borges, K., & Aldana, B. I. (2021) · Molecular Brain · doi:10.1186/s13041-021-00842-2 · Cited by 89 · see citing works

Glial Glutamine Homeostasis in Health and Disease

Andersen, J. V., & Schousboe, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03771-1 · Cited by 88 · see citing works

Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease

Qian, K., Bao, X., Li, Y., Wang, P., Guo, Q., Yang, P., Xu, S., Yu, F., Meng, R., Cheng, Y., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05795 · Cited by 87 · see citing works

What is ‘Alzheimer's disease’? The neuropathological heterogeneity of clinically defined Alzheimer's dementia

Mehta, R. I., & Schneider, J. A. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000912 · Cited by 84 · see citing works

Dietary nutrition for neurological disease therapy: Current status and future directions

Mao, X., Yin, X., Guan, Q.-W., Xia, Q., Yang, N., Zhou, H., Liu, Z., & Jin, W. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107861 · Cited by 84 · see citing works

Oxygen metabolism abnormality and Alzheimer's disease: An update

Liu, G., Yang, C., Wang, X., Chen, X., Wang, Y., & Le, W. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102955 · Cited by 83 · see citing works

The roles of microglia and astrocytes in neuroinflammation of Alzheimer’s disease

Han, J., Zhang, Z., Zhang, P., Yu, Q., Cheng, Q., Lu, Z., & Zong, S. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1575453 · Cited by 87 · see citing works

Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons

Meng, X., Song, Q., Liu, Z., Liu, X., Wang, Y., & Liu, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400544 · Cited by 78 · see citing works

Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects

Carelli, S., Rey, F., Ottolenghi, S., Zuccotti, G., & Samaja, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322430 · Cited by 78 · see citing works

Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's Disease

Salcedo, C., Andersen, J. V., Vinten, K. T., Pinborg, L. H., Waagepetersen, H. S., Freude, K., & Aldana, B. I. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.736580 · Cited by 77 · see citing works

Mitoprotective Effects of Centella asiatica (L.) Urb.: Anti-Inflammatory and Neuroprotective Opportunities in Neurodegenerative Disease

Wong, J. H., Barron, A. M., & Abdullah, J. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.687935 · Cited by 79 · see citing works

From Obesity to Hippocampal Neurodegeneration: Pathogenesis and Non-Pharmacological Interventions

Lee, T. H.-Y., & Yau, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010201 · Cited by 76 · see citing works

Sodium butyrate ameliorates the cognitive impairment of Alzheimer’s disease by regulating the metabolism of astrocytes

Wang, C., Zheng, D., Weng, F., Jin, Y., & He, L. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06025-0 · Cited by 76 · see citing works

Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective

Chaulagain, B., Gothwal, A., Lamptey, R. N. L., Trivedi, R., Mahanta, A. K., Layek, B., & Singh, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032710 · Cited by 82 · see citing works

Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies

Han, F. Y., Conboy-Schmidt, L., Quist‐Rybachuk, G., Volk, H. A., Zanghi, B. M., Pan, Y., & Borges, K. (2021) · Epilepsia · doi:10.1111/epi.16972 · Cited by 76 · see citing works

Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits

Zhang, Q., Song, Q., Yu, R., Wang, A., Jiang, G., Huang, Y., Chen, J., Xu, J., Wang, D., Chen, H., et al. (2023) · Advanced Science · doi:10.1002/advs.202204596 · Cited by 74 · see citing works

Emerging Roles of Endothelial Nitric Oxide in Preservation of Cognitive Health

Katusic, Z. S., d’Uscio, L. V., & He, T. (2023) · Stroke · doi:10.1161/strokeaha.122.041444 · Cited by 73 · see citing works

Insulin and Its Key Role for Mitochondrial Function/Dysfunction and Quality Control: A Shared Link between Dysmetabolism and Neurodegeneration

Galizzi, G., & Carlo, M. D. (2022) · Biology · doi:10.3390/biology11060943 · Cited by 76 · see citing works

Microbiota–gut–brain axis in health and neurological disease: Interactions between gut microbiota and the nervous system

He, Y., Wang, K., Su, N., Yuan, C., Zhang, N., Hu, X., Fu, Y., & Zhao, F. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70099 · Cited by 73 · see citing works

Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice

Stojakovic, A., Trushin, S., Sheu, A., Khalili, L., Chang, S.-Y., Li, X., Christensen, T., Salisbury, J. L., Geroux, R. E., Gateno, B., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01584-y · Cited by 72 · see citing works

Porous Fe3O4@COF-Immobilized gold nanoparticles with excellent catalytic performance for sensitive electrochemical detection of ATP

Li, H., Kou, B., Yuan, Y., Chai, Y., & Yuan, R. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113758 · Cited by 71 · see citing works

Can nutrition support healthy cognitive ageing and reduce dementia risk?

Jennings, A., Cunnane, S. C., & Minihane, A. M. (2020) · BMJ · doi:10.1136/bmj.m2269 · Cited by 69 · see citing works

Fasting: From Physiology to Pathology

Tang, D., Tang, Q., Huang, W., Zhang, Y., Tian, Y., & Fu, X. (2023) · Advanced Science · doi:10.1002/advs.202204487 · Cited by 71 · see citing works

State of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease

Rhea, E. M., Leclerc, M., Yassine, H. N., Capuano, A. W., Tong, H., Petyuk, V. A., Macauley, S. L., Fioramonti, X., Carmichael, O., Calon, F., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0814 · Cited by 70 · see citing works

Lactate metabolism and histone lactylation in the central nervous system disorders: impacts and molecular mechanisms

Wang, Y., Li, P., Xu, Y., Feng, L., Fang, Y., Song, G., Li, X., Zhu, Z., Wang, W., Mei, Q., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03303-4 · Cited by 71 · see citing works

Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders

Liang, Z., Currais, A. J. M., Soriano‐Castell, D., Schubert, D. A., & Maher, P. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107749 · Cited by 70 · see citing works

Metabolic reprogramming in ischemic stroke: when glycolytic overdrive meets lipid storm

Wang, Y., Ge, M., Wang, J., Xu, Y., Wang, N., & Xu, S. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08114-w · Cited by 75 · see citing works

Intracellular energy controls dynamics of stress-induced ribonucleoprotein granules

Wang, T., Tian, X., Kim, H. B., Jang, Y., Huang, Z., Na, C. H., & Wang, J. (2022) · Nature Communications · doi:10.1038/s41467-022-33079-1 · Cited by 67 · see citing works

Lactate Supply Overtakes Glucose When Neural Computational and Cognitive Loads Scale Up

Dembitskaya, Y., Piette, C., Siaume‐Perez, S., Berry, H., Magistretti, P. J., & Venance, L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212004119 · Cited by 69 · see citing works

The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat

Stacpoole, P. W., & McCall, C. E. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.02.007 · Cited by 68 · see citing works

Metabolic Crosstalk between Liver and Brain: From Diseases to Mechanisms

Yang, X., Qiu, K., Jiang, Y., Huang, Y., Zhang, Y., & Liao, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147621 · Cited by 69 · see citing works

The Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review

Caradonna, E., Nemni, R., Bifone, A., Gandolfo, P., Costantino, L., Giordano, L., Mormone, E., Macula, A., Cuomo, M., Difruscolo, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144130 · Cited by 68 · see citing works

The metabolic costs of cognition

Jamadar, S. D., Behler, A., Deery, H. A., & Breakspear, M. J. (2025) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2024.11.010 · Cited by 68 · see citing works

Brain NAD Is Associated With ATP Energy Production and Membrane Phospholipid Turnover in Humans

Cuenoud, B. M., İpek, Ö., Shevlyakova, M., Beaumont, M., Cunnane, S. C., Rolf Gruetter, A., & Xin, L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.609517 · Cited by 67 · see citing works

Aberrant energy metabolism in Alzheimer’s disease

Yu, L., Jin, J., Xu, Y., & Zhu, X. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0024 · Cited by 66 · see citing works

Organelle‐Targeting Nanoparticles

Soukar, J., Peppas, N., & Gaharwar, A. (2025) · Advancement of science · doi:10.1002/advs.202411720 · Cited by 67 · see citing works

Pathophysiology of Lipid Droplets in Neuroglia

Smolič, T., Zorec, R., & Vardjan, N. (2021) · Antioxidants · doi:10.3390/antiox11010022 · Cited by 69 · see citing works

The Cause of Alzheimer’s Disease: The Theory of Multipathology Convergence to Chronic Neuronal Stress

Decourt, B., D’Souza, G. X., Shi, J., Ritter, A., Suazo, J., & Sabbagh, M. N. (2022) · Aging and disease · doi:10.14336/ad.2021.0529 · Cited by 69 · see citing works

Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage

Chen, W., Guo, C., Feng, H., & Chen, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.615451 · Cited by 63 · see citing works

Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders

Kelly, D., & Rothwell, P. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.830064 · Cited by 66 · see citing works

Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing

Myette‐Côté, É., Soto-Mota, A., & Cunnane, S. C. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521003883 · Cited by 43 · see citing works

Metabolic therapeutic targets in Alzheimer’s disease

Ignatius Raymond Peter, L., Chatterjee, D., Chrishone, A. F., & Francis, D. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.010

Brain glucose and ketone utilization in brain aging and neurodegenerative diseases

Kapogiannis, D., & Avgerinos, K. I. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.015 · Cited by 63 · see citing works

Therapeutic targeting of brain bioenergetics in Alzheimer’s disease addressing insulin resistance, glucose hypometabolism, and mitochondrial dysfunction

Jangra, J., Mahindru, I., & Kumar, R. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.005

Glucose, glycolysis, and neurodegenerative disorders

Coelho, P., & Rego, A. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91704-9.00012-4 · Cited by 2 · see citing works